An improved on-line solid phase extraction coupled HPLC-MS/MS system for quantification of sifuvirtide in human plasma. 2010

Qing-Qing Wang, and Shen-Si Xiang, and Yan-Bo Jia, and Lun Ou, and Fang Chen, and Hai-Feng Song, and Qing Liang, and Dan Ju
Laboratory of Drug Metabolism and Pharmacokinetics, Beijing Institute of Radiation Medicine, Beijing 100850, China.

An improved liquid chromatographic method with on-line solid phase extraction (SPE) and tandem mass spectrometric detection was optimised for quantification of the anti-HIV peptide Sifuvirtide in human plasma. The SPE sorbents, loading buffer composition and other aspects of the on-line SPE column were investigated in detail for efficiently extracting the interesting peptides and simultaneously discarding the large amount of proteins. The gradient elution program was optimised on the analysis column to decrease the matrix effect and obtain excellent selectivity. The multiple charge ion at m/z 946.4 of Sifuvirtide was quantified by a linear ion trap mass spectrometer, operating in the positive mode, and selective reaction monitoring (SRM) acquisition. Method validation results demonstrated that the linear calibration curve covered a range of 6.1-6250 ng/mL, and the correlation coefficients (r(2)) were above 0.992. The lower limit of detection (LLOD) with a signal-to-noise (S/N) ratio higher than 10 was 6.1 ng/mL. The accuracy ranged from -7.6 to 10.6%, and the intra- and inter-batch precisions were less than 8.7% and 5.5%, respectively. Finally, more than nine hundred of samples from a clinical trial was completely analyzed using this on-line SPE coupled HPLC-MS/MS system in one single week, due to the rapid run-time of individual sample (6.5 min).

UI MeSH Term Description Entries
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005561 Formates Derivatives of formic acids. Included under this heading are a broad variety of acid forms, salts, esters, and amides that are formed with a single carbon carboxy group. Formic Acids,Acids, Formic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000097 Acetonitriles Compounds in which a methyl group is attached to the cyano moiety. Cyanomethane,Cyanomethanes,Ethane Nitriles,Methyl Cyanide,Methyl Cyanides,Cyanide, Methyl,Cyanides, Methyl,Nitriles, Ethane
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D016014 Linear Models Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression. Linear Regression,Log-Linear Models,Models, Linear,Linear Model,Linear Regressions,Log Linear Models,Log-Linear Model,Model, Linear,Model, Log-Linear,Models, Log-Linear,Regression, Linear,Regressions, Linear
D052616 Solid Phase Extraction An extraction method that separates analytes using a solid phase and a liquid phase. It is used for preparative sample cleanup before analysis by CHROMATOGRAPHY and other analytical methods. Extraction, Solid Phase,Extractions, Solid Phase,Solid Phase Extractions
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem

Related Publications

Qing-Qing Wang, and Shen-Si Xiang, and Yan-Bo Jia, and Lun Ou, and Fang Chen, and Hai-Feng Song, and Qing Liang, and Dan Ju
October 2005, Therapeutic drug monitoring,
Qing-Qing Wang, and Shen-Si Xiang, and Yan-Bo Jia, and Lun Ou, and Fang Chen, and Hai-Feng Song, and Qing Liang, and Dan Ju
June 2009, Analytical and bioanalytical chemistry,
Qing-Qing Wang, and Shen-Si Xiang, and Yan-Bo Jia, and Lun Ou, and Fang Chen, and Hai-Feng Song, and Qing Liang, and Dan Ju
January 2005, Rapid communications in mass spectrometry : RCM,
Qing-Qing Wang, and Shen-Si Xiang, and Yan-Bo Jia, and Lun Ou, and Fang Chen, and Hai-Feng Song, and Qing Liang, and Dan Ju
April 2009, Talanta,
Qing-Qing Wang, and Shen-Si Xiang, and Yan-Bo Jia, and Lun Ou, and Fang Chen, and Hai-Feng Song, and Qing Liang, and Dan Ju
April 2021, Molecules (Basel, Switzerland),
Qing-Qing Wang, and Shen-Si Xiang, and Yan-Bo Jia, and Lun Ou, and Fang Chen, and Hai-Feng Song, and Qing Liang, and Dan Ju
January 2011, Talanta,
Qing-Qing Wang, and Shen-Si Xiang, and Yan-Bo Jia, and Lun Ou, and Fang Chen, and Hai-Feng Song, and Qing Liang, and Dan Ju
September 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Qing-Qing Wang, and Shen-Si Xiang, and Yan-Bo Jia, and Lun Ou, and Fang Chen, and Hai-Feng Song, and Qing Liang, and Dan Ju
June 2005, Journal of agricultural and food chemistry,
Qing-Qing Wang, and Shen-Si Xiang, and Yan-Bo Jia, and Lun Ou, and Fang Chen, and Hai-Feng Song, and Qing Liang, and Dan Ju
January 2012, Analytical and bioanalytical chemistry,
Qing-Qing Wang, and Shen-Si Xiang, and Yan-Bo Jia, and Lun Ou, and Fang Chen, and Hai-Feng Song, and Qing Liang, and Dan Ju
April 1997, Clinical chemistry,
Copied contents to your clipboard!